Eisai cuts 25% of US staff
April 10, 2015Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff
Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …
Shire gets FDA boost – but suffers trial setback
April 10, 2015Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625
Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …
RSA hires senior consultant
April 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kris Richards, rsa
Life sciences executive search and interims specialist firm RSA has appointed a new senior consultant to its executive interims team. …
Over one billion drugs dispensed in England in 2014, NHS report shows
April 9, 2015Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions
Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Former FDA commissioner named as Institute of Medicine foreign secretary
April 9, 2015Manufacturing and Production, Medical Communications, Research and Development Dr Margaret Hamburg, FDA, IOM, Institute of Medicine, Margaret Hamburg
Former commissioner of the US Food and Drug Administration Margaret Hamburg has been appointed as the next foreign secretary of …
Cello Health Consulting gains senior marketer
April 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, beverly hope, consulting, health
Healthcare strategic marketing consultancy Cello Health Consulting has appointed pharma marketer Beverly Hope as a senior consultant for its brand and portfolio …
Gilead’s next-generation HIV drug to be FDA assessed
April 8, 2015Research and Development, Sales and Marketing F/TAF, FDA, Gilead, HIV, Tenofovir Alafenamide, emtricitabine
Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …
Amgen’s colorectal cancer drug EU approved
April 8, 2015Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa
The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …
FDA to look again at Novo Nordisk insulin submissions
April 8, 2015Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec
Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …
EU nod for Roche cancer drug and chemotherapy
April 8, 2015Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD
The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer. Avastin (bevacizumab) …
Vaxon Biotech appoints founder as chief executive
April 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Konstantinos Kosmatopoulos, vaxon biotech
Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …
Takeda expands in the United Arab Emirates
April 7, 2015Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east
Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …
Antibiotic resistance outbreak ‘could kill 80,000’, report warns
April 7, 2015Research and Development, Sales and Marketing AMR, Nabriva Therapeutics, antibiotic resistance, bacteria, blood infections, infections
An antibiotic-resistant blood infection outbreak could lead to 80,000 deaths, according to a government report on threats to the UK. …
Hundreds of jobs threatened after big pharma deals close
April 7, 2015Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix
Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …
Refining UK market access
April 7, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access
“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …
BMS enters gene therapy development deal
April 7, 2015Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure
Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …
Shire plots new ADHD drug approval
April 7, 2015Sales and Marketing ADHD, FDA, SHP465, Shire, Vyvanse, clinical trials, paediatrics
Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …
Merck Ebola vaccine safe and effective in latest trials
April 2, 2015Research and Development, Sales and Marketing Ebola, Merck, National Institutes of Health, VSV-ZEBOV, Vaccine, Walter Reed Army Institute of Research, newlink
Merck and NewLink’s experimental Ebola vaccine has been found to be safe and effective in a new trial in the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
